pphmtoolong, lets just say that they know that they have a great drug. At the same time they learned their lesson two years ago and don't want to over excite us. Garnick's presentation was "regulatory affairs 101" for the shareholders. I talked to him In the last two shareholders meetings and he keeps his poker face. Remember he is being sued too. My opinion is that we have to wait a couple of years for the drug to get approved. Meanwhile, what will bring the share price up majorly would be a partnership and modestly is all the results from early stage studies and collaboration studies. Got to go.
News 
Market Data 
Discover 
